Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Net Income (2016 - 2025)

Acro Biomedical has reported Net Income over the past 10 years, most recently at $42526.0 for Q4 2025.

  • Quarterly results put Net Income at $42526.0 for Q4 2025, up 498.44% from a year ago — trailing twelve months through Dec 2025 was -$101146.0 (down 139.13% YoY), and the annual figure for FY2025 was -$101146.0, down 139.13%.
  • Net Income for Q4 2025 was $42526.0 at Acro Biomedical, up from -$117809.0 in the prior quarter.
  • Over the last five years, Net Income for ACBM hit a ceiling of $2.2 million in Q4 2021 and a floor of -$4.0 million in Q3 2022.
  • Median Net Income over the past 5 years was -$88651.5 (2021), compared with a mean of -$1.3 million.
  • Biggest five-year swings in Net Income: soared 3706.19% in 2021 and later crashed 6503.69% in 2022.
  • Acro Biomedical's Net Income stood at $2.2 million in 2021, then crashed by 276.63% to -$3.9 million in 2022, then soared by 99.54% to -$18240.0 in 2023, then surged by 41.49% to -$10673.0 in 2024, then surged by 498.44% to $42526.0 in 2025.
  • The last three reported values for Net Income were $42526.0 (Q4 2025), -$117809.0 (Q3 2025), and -$15562.0 (Q2 2025) per Business Quant data.